Malaria News and Research

Latest Malaria News and Research

Opinions: Using taxes to reduce poverty; fighting TB; meeting global food demands

To improve living standards and create jobs," African governments "need to provide their citizens with better health care, better education, more infrastructure. How to pay for this - in a way that is both fair and efficient - is a question that all governments face," Mark Plant, deputy director of the IMF's African Department, writes in a BusinessDay opinion piece where he describes how increased tax revenues in several African countries have led to "in-roads into poverty reduction."

25 Mar 2011

WHO report urges countries to step up fight against drug-resistant TB

A WHO report released Wednesday says countries with the highest drug-resistant tuberculosis burdens are making progress in addressing the disease, "but despite the recent scale up in efforts, the world needs to do much more to get care to all [multi-drug resistant] patients who need it," WHO Director-General Margaret Chan said, Times LIVE reports.

24 Mar 2011

ISEFC, TB Alliance to establish Global Health R&D Center of China

The International Scientific Exchange Foundation of China, a technical public foundation dedicated to promoting and advancing scientific development, cooperation, and exchange, today signed a Memorandum of Understanding with the Global Alliance for TB Drug Development, to work together to establish the Global Health R&D Center of China, a world-class organization focused on developing innovative new treatments for public health diseases, including tuberculosis, malaria, and HIV/AIDS.

24 Mar 2011

WHO releases first list of 30 priority medicines for women, children

The WHO on Monday released a list of 30 medicines that "are essential for treating common diseases of mothers and children," Ghana News Agency reports (3/21).

23 Mar 2011

Northwest Russian women breast milk consists of more POPs than Norwegian

Russian women living in Northwest Russia are more exposed to environmental toxins than Norwegian women. In spite of this, PhD candidate Anuschka Polder urges Russian women to breastfeed their babies.

22 Mar 2011

Government of Canada commits to contribute towards global effort to combat malaria

Canada is delivering on its commitment to help the world's most vulnerable, thanks to new developments which will provide an affordable, reliable, and stable treatment for malaria that will save millions of lives, especially those of women and children in Africa.

19 Mar 2011

U.S. officials discuss proposed foreign aid cuts at House Foreign Affairs Committee hearing

Proposed budget cuts could be "absolutely devastating" for American foreign aid programs, USAID Administrator Rajiv Shah said at a House Foreign Affairs Committee hearing on Wednesday, the Associated Press reports.

18 Mar 2011

Anacor Pharma, MMV enter agreement to develop AN3661 for malaria treatment

Anacor Pharmaceuticals announced today that it has entered into a development agreement with Medicines for Malaria Venture to develop Anacor's compound AN3661 for the treatment of malaria.

18 Mar 2011

Inovio signs agreement with OncoSec to sell non-DNA cancer vaccine technology

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has signed an agreement with OncoSec Medical Inc. providing for the sale to OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.

17 Mar 2011

Global Fund taps former HHS Sec., former President of Botswana to lead external investigation of its financial controls

The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday named former HHS Secretary Michael Leavitt and former President of Botswana Festus Mogae to co-chair "an external review of its financial systems, amid heightened scrutiny from donors over misuse of some grants and a potential funding reduction from the U.S.," the Wall Street Journal reports.

17 Mar 2011

Fresh insight into parasite's reproductive strategy can prevent malaria spread

Fresh insight into the way the parasite that causes malaria reproduces could lead to new treatments to help curb the spread of the disease.

17 Mar 2011

Biomagnetics Diagnostics initiates miniaturization process for optical biosensor platform

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has begun the process of miniaturizing the optical biosensor platform developed in cooperation with Los Alamos National Laboratory.

16 Mar 2011

Malaria drug shrinks, slows resistant pancreatic tumors

Dana-Farber Cancer Institute scientists report they have shrunk or slowed the growth of notoriously resistant pancreatic tumors in mice, using a drug routinely prescribed for malaria and rheumatoid arthritis.

16 Mar 2011

Artesunate more effective against severe malaria

Quinine should no longer be the drug of choice for treating severe malaria, according to an updated systematic review by Cochrane researchers. It is now evident that the antimalarial drug artesunate, which is derived from herbs used in Chinese medicine, is more effective at preventing death in patients with severe malaria.

16 Mar 2011

ALMA receives ExxonMobil $250,000 grant to combat malaria

The African Leaders Malaria Alliance, an alliance of 39 African leaders, announced today that it has been awarded a $250,000 grant from the ExxonMobil Foundation to help with its campaign to combat malaria.

16 Mar 2011

OncoSec signs agreement with Inovio to purchase non-DNA cancer vaccine technology

OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.

15 Mar 2011

Global chronic disease burdens are increasing rapidly: Research

Those working for healthier humans around the globe are making headway in fighting communicable diseases such as AIDS, malaria and diarrheal illness, according to research from the Frederick S. Pardee Center for International Futures in the University of Denver's Josef Korbel School of International Studies.

15 Mar 2011

New findings may open doors for vaccine development against HIV, tuberculosis

Alum is an adjuvant used in many common vaccines, and Canadian researchers have now discovered how it works. The research by scientists from the University of Calgary's Faculty of Medicine is published in the March 13 online edition of Nature Medicine.

15 Mar 2011

ChronTech initiates ChronVac-C DNA vaccine Phase IIb study against HCV

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its partner, ChronTech Pharma AB, has initiated a Phase IIb clinical study of its ChronVac-C DNA vaccine for hepatitis C virus, delivered by Inovio's proprietary electroporation DNA vaccine delivery technology, in combination with standard of care.

14 Mar 2011

CHF signs agreement with Global Fund to implement HIV/AIDS program in Colombia

CHF International, the Silver Spring-MD based international development and humanitarian assistance organization, announced it signed an agreement with the Global Fund to Fight AIDS, Tuberculosis and Malaria to implement a two-year HIV and AIDS program in Colombia, with the possibility to extend it for another three years.

11 Mar 2011